中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:(Haigang LI)

1.Expression of paxillin and vascular endothelial growth factor in lung carcinoma and its clinical implications.

Wanli ZUO ; Haigang LI

Chinese Journal of Practical Internal Medicine 2001;0(02):-

2.Hypothesis of cyclooxygenase isoenzymes

Haigang ZHANG ; Xiaohui LI ;

Chinese Pharmacological Bulletin 1987;0(01):-

3.Hepatectomy combined with intraarterial and intraportal chemotherapy for the treatment of hepatocellular carcinoma

Honghao LI ; Jisheng CHEN ; Haigang LI

Chinese Journal of General Surgery 2001;0(08):-

4.Expression of Nitric Oxide Synthase 3 and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma

Kaihong HUANG ; Zhiqing HUANG ; Haigang LI

Journal of Sun Yat-sen University(Medical Sciences) 2001;22(3):199-201

5.Expression and significance of survivin and cyclin D_1 in hepatic cellular carcinoma.

Jian LIANG ; Kaihong HUANG ; Haigang LI

Chinese Journal of Practical Internal Medicine 2001;0(03):-

6.Effects of ERC61-Extract from Rhizoma Curcumae on Hematopoietic Functions in Mice Treated by Chemotherapy

Mao XING ; Xiaohui LI ; Haigang ZHANG

China Pharmacy 2007;0(27):-

7.Determination of Curdione in Nano-micelles Loaded with Curdione by UV-Vis Spectrophotometry

Mao XING ; Xiaohui LI ; Haigang ZHANG

China Pharmacy 2007;0(30):-

8.Efficacy and safety of esomeprazole enteric coated capsules in the treatment of duodenal ulcer

Song ZHU ; Haigang ZHOU ; Zongshuang LI

Chinese Journal of Biochemical Pharmaceutics 2017;37(6):335-336

9.Expression of nitric oxide synthase and its clinical significance in hepatic cellular carcinoma

Haigang LI ; Qiaozhu SU ; Shunong LI ; Shuku DONG

Chinese Journal of Pathophysiology 2000;0(12):-

10.Elementary Evaluation of the Safety of Chitosan DCX-16

Jian ZENG ; Xiaohui LI ; Yuehua HUANG ; Haigang ZHANG ; Shuhui LI

China Pharmacy 1991;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO